glyburide oral suspension

临床试验

计划入组 56 人 · 首次发布于 2024 年 12 月 18 日

招募中

NCT05426681

Spinal Cord Injury Neuroprotection With Glyburide

计划入组 12 人 · 首次发布于 2022 年 6 月 22 日

已完成

NCT04550546

Effects of Nystatin Suspension Oral Application on Oral Microbial Community

计划入组 20 人 · 首次发布于 2020 年 9 月 16 日

药物

查看全部 1301 →

Small Molecule

Approved

Glyburide(Diabeta, Glucovance, Glynase, Amglidia)

生产企业：Sanofi aventis us llc, Actavis totowa llc，另有 8 家

相关疾病：Gestational Diabetes Mellitus (GDM), Glycemic Control，另有 1 项

C₂₃H₂₈ClN₃O₅S · Rx

Valacyclovir oral suspension (Hyloris Pharmaceuticals)

Amniotic Suspension Allograft

机构

查看全部 85 →

Oral-B Laboratories

United States

Philips Oral Healthcare

United States

ORAL RECONSTRUCTION FOUNDATION

United States

资讯

查看全部 5708 →

去年

Eton Pharmaceuticals Acquires U.S. Rights to Amglidia for Neonatal Diabetes

去年

FDA Approves First Lamotrigine Oral Suspension for Epilepsy and Bipolar Disorder Treatment

去年

临床试验

Phase 1 BIO 300 Oral Suspension

Spinal Cord Injury Neuroprotection With Glyburide

Effects of Nystatin Suspension Oral Application on Oral Microbial Community

药物

Glyburide(Diabeta, Glucovance, Glynase, Amglidia)

Valacyclovir oral suspension (Hyloris Pharmaceuticals)

Amniotic Suspension Allograft

机构

Oral-B Laboratories

Philips Oral Healthcare

ORAL RECONSTRUCTION FOUNDATION

资讯

Eton Pharmaceuticals Acquires U.S. Rights to Amglidia for Neonatal Diabetes

FDA Approves First Lamotrigine Oral Suspension for Epilepsy and Bipolar Disorder Treatment

Emergent BioSolutions Secures $17 Million BARDA Contract for Smallpox Antiviral TEMBEXA Oral Suspension